Executive Summary
A single massive $20.65B cost-plus contract awarded to Lockheed Martin Services, LLC for Y-12 plant management through Feb 2027 signals strong revenue visibility in DOE facilities operations. Despite zero outlays to date, the fully funded structure and full/open competition award underscore long-term stability for Lockheed Martin in NAICS 561210 services.
Investors should monitor DOE budget execution amid funding risks, with potential follow-on opportunities post-2027.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from February 28, 2026.
Investment Signals (1)
- $20.65B DOE Y-12 M&O Contract Extension (HIGH)▲
Definitive cost-plus award fee contract provides 43-year revenue stability through 2027 for Lockheed Martin in operating government R&D GOCO facilities.
Risk Flags (2)
- Execution [HIGH RISK]▼
Zero outlays despite long performance period to 2027 signals potential delays in funding or contract activation.
- Market [MEDIUM RISK]▼
Reliance on DOE budget for cost-plus reimbursements exposes to federal funding uncertainties.
Opportunities (1)
- ◆
Minimal gap between total obligation ($20.646B) and base+options ($20.647B) indicates fully funded structure with potential for post-2027 follow-on Y-12 work.
Sector Themes (1)
- ◆
Full/open competition award of $20.65B over 43 years highlights preference for established corporate providers in facilities management (NAICS 561210).
Watch List (2)
- 👁
{"entity"=>"Lockheed Martin Y-12 Contract Outlays", "reason"=>"Zero funds disbursed on $20.65B obligation requires tracking to confirm revenue realization.", "trigger"=>"Initial outlays >$100M or delays beyond Q2 2026"}
- 👁
{"entity"=>"DOE Oak Ridge Budget", "reason"=>"Cost-plus structure ties cash flows to federal appropriations for Y-12 programs.", "trigger"=>"Budget cuts >10% or supplemental funding bills"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: High-Value Federal Grants ($5M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals
May 26, 2026
Big Pharma Approvals — May 26, 2026
Big Pharma Approvals